M.D. v. Google LLC
- Martinez-Olguin
- 3:24-cv-06369
- U.S. District Court · Northern District of California
- 11
In M.D. v. Google LLC, Judge Martinez-Olguin granted defendants’ motions to dismiss, allowing plaintiffs to amend.
The order affects plaintiffs M.D., O.F., and J.P., the proposed California, Pennsylvania, and Maryland classes, and defendants Google LLC and Meta Platforms, Inc. The complaint was dismissed, but the plaintiffs were allowed to amend it by October 24, 2025.
What happened
In M.D. v. Google LLC, plaintiffs alleged that Google and Meta collected personal health information, including information about erectile dysfunction prescriptions, from the BlueChew website. The plaintiffs brought claims under California privacy laws, the Pennsylvania Wiretapping Act, the Maryland Wiretapping and Electronic Surveillance Act, and the California Constitution, seeking to represent groups of affected users.
Google and Meta argued that users consented to the collection and sharing through BlueChew’s sign-up process and privacy policies. The court found that BlueChew’s earlier policies did not clearly notify users that their private health information would be shared with Google and Meta for online advertising. But the court concluded that the complaint did not plausibly allege that the challenged data-sharing practices occurred before users consented under BlueChew’s August 2024 policy.
Judge Martinez-Olguin granted the defendants’ requests for judicial notice and granted their motions to dismiss the complaint. The court allowed the plaintiffs to file an amended complaint by October 24, 2025, and said that no parties or claims could be added without court permission or the defendants’ agreement.
The detailed version
- M.D. v. Google LLC · No. 3:24-cv-06369
- Martinez-Olguin
- Sept. 23, 2025
Background
This putative data-privacy class action concerns information allegedly collected from the BlueChew website. BlueChew provided a platform through which users connected with health-care providers to obtain diagnosis and treatment for erectile dysfunction. Plaintiffs M.D., O.F., and J.P. alleged that Google and Meta intercepted information sent through the website using tools including Google Analytics and the Facebook Tracking Pixel.
The alleged information included names, birthdays, email addresses, pseudonymous identifiers, website activity, and information about prescription erectile dysfunction medications. Plaintiffs alleged that the defendants used the information for targeted advertising. The operative complaint asserted claims under California Penal Code sections 631 and 632, California constitutional privacy law, the Pennsylvania Wiretapping Act, and the Maryland Wiretapping and Electronic Surveillance Act. The plaintiffs sought to represent putative California, Pennsylvania, and Maryland classes.
Judicial Notice
The court granted Google’s and Meta’s requests for judicial notice of the existence of various website terms, privacy policies, and related materials. The court also considered those materials under the incorporation-by-reference doctrine, which can allow a court deciding a motion to dismiss to treat certain documents referred to in the complaint as part of the complaint.
Motions to Dismiss
The defendants moved to dismiss under Federal Rule of Civil Procedure 12(b)(6), which tests whether a complaint alleges enough facts to state a legally recognized and plausible claim. The court explained that all of the plaintiffs’ claims depended on showing that the alleged interception occurred without their consent.
The court rejected the defendants’ argument that the earlier BlueChew privacy policies conclusively established consent. Although those policies referred to analytics tools, cookies, tracking technologies, and some information sharing, the court found that they did not explicitly notify users that their private health information would be shared with Google or Meta for online advertising. The court also noted that the earlier policies stated that BlueChew did not share personal information with third parties for their own direct-marketing purposes. The court therefore found that those policies did not establish consent at the motion-to-dismiss stage.
The court reached a different conclusion about BlueChew’s August 2024 Privacy Policy. That policy disclosed use of the Meta Pixel and Google Analytics, stated that health information could be shared with third parties for advertising and data analysis, and omitted the earlier limitation concerning direct marketing. Plaintiffs’ counsel conceded at the hearing that the August 2024 policy established users’ consent to the data-collection practices.
The court nevertheless dismissed all claims because the complaint did not adequately allege that the challenged data-sharing practices were already occurring before the August 2024 policy gave consent. The court stated that, as alleged, the claims had not been made plausible because they lacked factual support showing that the practices predated consent.
Leave to Amend and Disposition
The court granted the defendants’ motions to dismiss the complaint. It did not determine that amendment would necessarily be futile and therefore granted plaintiffs leave to file an amended complaint addressing possible privacy violations occurring before adoption of the August 2024 Privacy Policy.
Plaintiffs could file an amended complaint no later than October 24, 2025. The order also stated that no parties or claims could be added without court permission or a stipulation by the defendants.
Read the full 11-page opinion on CourtListener, the free public archive maintained by the Free Law Project.